Presentation Content Overview

Disclaimer and Legal Notice

The Information Memorandum is prepared for informational purposes only and not as an investment solicitation. All figures and statistics are subject to change without prior notice, and financial estimates are preliminary. The company disclaims liability for inaccuracies, omissions, or typographical errors.

Executive Overview

Fischer Medical Ventures Limited (FMV) positions itself as an integrated AI-enabled healthcare platform spanning medical imaging, population-scale screening, and hospital digitization. The company describes itself as "Building the world's largest Healthcare AI Solutions Platform" with a focus on AI-enabled Medical Imaging, Population-scale Screening, and Hospital Digitization.

Strategic Ecosystem

The presentation outlines relationships between three operating brands: FMV, Time Medical, and FlynnCare, describing them as combining into "one integrated healthcare innovation engine."

Vision and Mission

The company's vision is "To make early detection and preventive healthcare universally accessible through intelligent, integrated and affordable medical technology." Their mission is "To deploy AI-enabled diagnostic and screening platforms that digitize healthcare delivery from primary care to tertiary hospitals."

Leadership and Governance

Board of Directors:

  • Ravindran Govindan - Chairman & Managing Director (Former Chairman & President (APAC), Fisher Scientific Inc., 45+ years experience)
  • Svetlana Rao Raviwada - Whole Time Director (Electronics & Communications Engineer, led establishment of FMV India operations)
  • Khairy Jamaluddin Abu Bakar - Independent Director (Former Minister of Health, Malaysia, led national COVID-19 response)
  • Jaya Ankur Singhania - Independent Director (15+ years in corporate governance and legal advisory)
  • Richard Chan Sing En - Independent Director (30+ years in private equity and corporate finance)
  • Dr. Syed Jalaluddin - Independent Director (Distinguished academic, scientist & corporate leader)

Key Managerial Personnel:

  • Shankar Varadharajan - FMV Group Chief Operating Officer (30+ years in investment banking, project financing)
  • Vivek Balasubramanian - FMV Group Chief Financial Officer (Chartered Accountant, previously at PWC and KPMG M&A)
  • Simon Yeung - Chief Technology Officer, Time Medical (Co-founder with 20+ years MRI system development experience)
  • Amol Mhaskar - Chief Operating Officer, Time Medical (13+ years expertise in Field Engineering, MRI systems)
  • Alagaraja Ravindra Raja - Chief Technology Officer, Flynncare (20+ years in healthcare, cloud computing, DICOM, HL7)
  • Karthikeyan R - Chief Solutions Architect, Flynncare (19+ years in healthcare product development)
  • Commander Yogendra Sharma - VP-Plant Operations, Time Medical (20+ years Indian Navy, operations expertise)

Product Portfolio Details

MRI Diagnostic Range:

  • PICA/PANION/AURA (0.35T/0.7T) - Open architecture, pediatric, weight-bearing with FDA/CE/CDSCO approvals
  • MICA/MICA Smart (1.5T) - General-purpose, high performance with CDSCO approval
  • QUIN (1.5T) - Helium Free High-performance neurology & cardiac with CDSCO approval
  • NEONA - Specialized MRI
  • NEXA/N-NEXA (3.0T)
  • Nova 7T (7.0T) - Ultra-high field research platform

Open Architecture MRI Solutions: PICA 0.35T and AURA 0.7T focused on comfort, accessibility and cost-effectiveness

Closed Bore MRI Excellence: MICA, QUIN, NEONA, NEXA and Nova 7T covering premium and ultra-high field imaging

MRI Screening Portfolio: VEGA, VEGA+ and MMIS systems purpose-built for stroke, vascular and population screening

Surgical Innovation: Medharanya Suite & Intraoperative MRI including DRIS, DRIS+ and integrated neuro-surgical ecosystem

CT Imaging Portfolio: Clarion CT family from 32-slice to wide-bore configurations

X-Ray Portfolio:

  • RX90 (CDSCO, BIS AERB approved; 2-8 mA; 24 APR; 40-90 kV)
  • RX706 (CDSCO, BIS AERB approved; 2-6 mA; 18 APR; 40-70 kV)
  • RX590 (CDSCO, BIS AERB approved; 2-5 mA; 24 APR; 40-70 kV)
  • RX910 (CDSCO, BIS AERB approved; 2-10 mA; 24 APR; 40-90 kV)
  • C-ARM (CDSCO, BIS AERB approved; 1 mA-25mA; 40-125 kV)

Portable X-Ray machines feature battery-powered operation with more than 150 images per charge, compact size (W-228mm x D-137mm x H-188mm), and include APR Technology, high voltage capability, and safety features.

Mammography Solutions: Navigator series with AI-assisted breast cancer screening and tomosynthesis

Technology Platforms

Integrated Healthcare Ecosystem: Hybrid cloud architecture enabling "one patient, one document" and 360° patient journey

MIDAS - Unified AI Healthcare Screening Ecosystem: Integrated AI-powered platform for multi-disciplinary early disease detection through single screening workflow covering:

  • Oral Cancer (Smartphone imaging + AI lesion classification)
  • Breast Cancer (AI density + lesion analysis on mammography)
  • Cervical Screening (Colposcopy AI + HPV risk integration)
  • AI Fundus (Diabetic retinopathy + glaucoma + AMD screening)
  • Cardiac Risk (ECG + biomarkers + AI risk scoring)
  • Neuropathy (Sensory testing + AI peripheral neuropathy detection)

LIVE Dx - Population Screening Platform: Operational platform for population-scale screening with tele-health, remote monitoring and predictive analytics

Clinics 2.0 Platform: Specialty EHR, HIS, practice management, telemedicine, AI insights and device interoperability

ATLAS - AI Healthcare Analytics Platform: Four-stage analytics maturity engine from descriptive to prescriptive analytics

Additional Technologies and Initiatives

NanoMedic - SpinCare Regenerative Skin Technology: World's first portable electrospinning system for direct-to-patient regenerative skin substitute application

Obelab - Portable Brain Imaging Platform: Functional near-infrared (fNIRS) and cerebral oximetry devices for research and clinical mental-health care

Nervotec - Contactless Vital Signs Measurement: Predictive healthcare via 60-second facial scan measuring HR, HRV, Respiration Rate, SpO₂, Stress Level, and Emotional State

Nanyang Biologics - AI Drug Discovery Platform: Next-generation natural-compound drug discovery built on NVIDIA + HPE infrastructure with NTU joint research

CareViva Nutraceutical Portfolio: Evidence-based nutraceutical products across four categories:

  • CAREVIVA ONCOLOGY (Tumour protection, proven efficacy inhibits tumor growth)
  • CAREVIVA METABOLIC HEALTH (AdiCare, adipose health, proven efficacy for browning of white fat)
  • CAREVIVA LIVER HEALTH (LivHealth, fatty liver reversal, proven efficacy induces lipid clearance)
  • CAREVIVA CARDIOVASCULAR (CardoaViva, foam cell prevention, proven efficacy inhibits foam cell formation)

Screening Frameworks

4T4TB - TB Screening Framework: Trace, Test, Treat, Track workflow built on portable AI X-Ray technology

SHIELD - Cancer Screening Framework: Screen, Highlight, Investigate, Empower, Long-term monitoring, Develop framework

Corporate Health Screening: Workforce wellness, women's health, mental wellness and ESG-linked healthcare programs